0

Close
 
Upcoming Allied Market Research
2023
Nephrology And Urology Devices Market

Nephrology and Urology Devices Market

by Type (Dialysis Equipment, Urinary Stone Treatment devices, Urinary Incontinence Pelvic Organ Prolapsed, Endoscopy Devices, Benign Prostatic Hyperplasia Treatment Devices): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A00324
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Nephrology And Urology Devices Market

Request Now !

Nephrology and urology devices are medical devices that are used for the treatment of   urinary system and kidney diseases such as chronic kidney diseases (CKD), urinary incontinence and pelvic organ prolapse, kidney stone, benign prostatic hyperplasia (BPH) and end stage renal disease (ESRD). According to WHO, more than 190 million patients suffer from chronic renal failure and undergo renal dialysis and over 220 million males suffer from diseases associated with prostate glands such as swelling that results in blockage of the flow of urine through the body. This rising incidences of kidney and urology diseases has shifted the inclination of physicians towards use of highly advanced nephrology and urology devices that significantly reduce treatment and recovery time. 

The major driving factor for this market is the growing aging population and prevalence of chronic kidney diseases. Innovation in urology devices and an increase in healthcare expenditure will also supplement the growth of this market. However, the high cost associated with these devices hinders the growth of this market. Growing awareness about benefits such as reduced treatment and recovery time among renal disease patients is fuelling the demand for nephrology and urology devices.

Nephrology and Urology Devices market by Type

Nephrology and Urology devices market is segmented by type into dialysis equipment, urinary stone treatment devices, urinary incontinence & pelvic organ prolapse devices, endoscopy devices and benign prosthetic hyperplasia treatment devices. Dialysis equipment is the largest segment of the market due to rising incidences of chronic kidney diseases.

Nephrology and Urology Devices market by Geography 

Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA. Currently, Europe is the largest region in the nephrology and urology devices market with leading dialysis and sacral neurostimulation market. North America is the second largest market and is expected to expand its sacral neurostimulation market in the coming years. 

Competitive Analysis

Baxter International, C.R.Bard, Fresenius Medical Care, Nikkiso Co. Ltd, Dornier Medtech is some major key players in this market. Product launch, merger and acquisition, and research and development are the competitive strategies adopted by these players. In Sep 2013, Baxter acquired Gambro, a medical device company. This acquisition expands Baxter’s dialysis product portfolio and its geographic presence in the dialysis business.

HIGH-LEVEL ANALYSIS

Porter’s Five Forces model reveals that the bargaining power of suppliers is high as suppliers are producing highly differentiated products. High switching cost for these differentiated products lowers the bargaining power of buyers. However, high initial investment is required to startup these device-manufacturing units. This leads to a minimal threat from new entrants. The market is highly fragmented and a number of players are coming up with new innovative products, which intensify the competition in the market. Key players and their strategies are identified and analyzed to develop a market entry and expansion strategy. Driving and limiting factors affecting the growth of nephrology and urology devices market are discussed in the report.

KEY BENEFITS

  • The report provides throws light on the efficient current trends. Based on understanding of trends, revenues are forecast.
  • Analysis of key strategies adopted by market players would assist in providing in-depth understanding of the market intelligence.
  • Analysis of trends in various regions would help the companies to plan their strategies depending on the geographic region.
  • Emphasis is laid on key factors affecting the growth of global neurology and urology device market. These factors are critically analyzed to reveal the most  impacting factors in the market
  • Porter’s Five Forces analysis provides an insight into market dynamics and industry competition

 Nephrology and Urology Devices Market Report Highlights

Aspects Details
By Type
  • Dialysis Equipment
    • Hemodialysis
    • Peritoneal Dialysis
  • Urinary Stone Treatment devices
    • Uretral Stents
    • Lithotripsy
  • Urinary Incontinence & Pelvic Organ Prolapsed
    • Sacral Neuromodulation
    • Vaginal Meshes & Slings
    • Urethral inserts & pessaries
  • Endoscopy Devices
  • Benign Prostatic Hyperplasia Treatment Devices
    • Catheter Ablation
    • Prostatic stents
    • Other devices
By GEOGRAPHY
  • North America
  • Europe
  • Asia-Pacific
  • LAMEA
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: NEPHROLOGY AND UROLOGY DEVICES MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Dialysis Equipment

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Hemodialysis

        • 4.2.4.1. Market Size and Forecast

      • 4.2.4. Peritoneal Dialysis

        • 4.2.4.1. Market Size and Forecast

    • 4.3. Urinary Stone Treatment Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Uretral Stents

        • 4.3.4.1. Market Size and Forecast

      • 4.3.4. Lithotripsy

        • 4.3.4.1. Market Size and Forecast

    • 4.4. Urinary Incontinence Pelvic Organ Prolapsed

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

      • 4.4.4. Sacral Neuromodulation

        • 4.4.4.1. Market Size and Forecast

      • 4.4.4. Vaginal Meshes Slings

        • 4.4.4.1. Market Size and Forecast

      • 4.4.4. Urethral inserts pessaries

        • 4.4.4.1. Market Size and Forecast

    • 4.5. Endoscopy Devices

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Benign Prostatic Hyperplasia Treatment Devices

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

      • 4.6.4. Catheter Ablation

        • 4.6.4.1. Market Size and Forecast

      • 4.6.4. Prostatic stents

        • 4.6.4.1. Market Size and Forecast

      • 4.6.4. Other devices

        • 4.6.4.1. Market Size and Forecast

  • CHAPTER 5: NEPHROLOGY AND UROLOGY DEVICES MARKET, BY REGION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Region

    • 5.2. North America

      • 5.2.1. Key Market Trends and Opportunities

      • 5.2.2. Market Size and Forecast, By Type

      • 5.2.3. Market Size and Forecast, By Country

      • 5.2.4. U.S. Nephrology And Urology Devices Market

        • 5.2.4.1. Market Size and Forecast, By Type

      • 5.2.5. Canada Nephrology And Urology Devices Market

        • 5.2.5.1. Market Size and Forecast, By Type

      • 5.2.6. Mexico Nephrology And Urology Devices Market

        • 5.2.6.1. Market Size and Forecast, By Type

    • 5.3. Europe

      • 5.3.1. Key Market Trends and Opportunities

      • 5.3.2. Market Size and Forecast, By Type

      • 5.3.3. Market Size and Forecast, By Country

      • 5.3.4. France Nephrology And Urology Devices Market

        • 5.3.4.1. Market Size and Forecast, By Type

      • 5.3.5. Germany Nephrology And Urology Devices Market

        • 5.3.5.1. Market Size and Forecast, By Type

      • 5.3.6. Italy Nephrology And Urology Devices Market

        • 5.3.6.1. Market Size and Forecast, By Type

      • 5.3.7. Spain Nephrology And Urology Devices Market

        • 5.3.7.1. Market Size and Forecast, By Type

      • 5.3.8. UK Nephrology And Urology Devices Market

        • 5.3.8.1. Market Size and Forecast, By Type

      • 5.3.9. Russia Nephrology And Urology Devices Market

        • 5.3.9.1. Market Size and Forecast, By Type

      • 5.3.10. Rest Of Europe Nephrology And Urology Devices Market

        • 5.3.10.1. Market Size and Forecast, By Type

    • 5.4. Asia-Pacific

      • 5.4.1. Key Market Trends and Opportunities

      • 5.4.2. Market Size and Forecast, By Type

      • 5.4.3. Market Size and Forecast, By Country

      • 5.4.4. China Nephrology And Urology Devices Market

        • 5.4.4.1. Market Size and Forecast, By Type

      • 5.4.5. Japan Nephrology And Urology Devices Market

        • 5.4.5.1. Market Size and Forecast, By Type

      • 5.4.6. India Nephrology And Urology Devices Market

        • 5.4.6.1. Market Size and Forecast, By Type

      • 5.4.7. South Korea Nephrology And Urology Devices Market

        • 5.4.7.1. Market Size and Forecast, By Type

      • 5.4.8. Australia Nephrology And Urology Devices Market

        • 5.4.8.1. Market Size and Forecast, By Type

      • 5.4.9. Thailand Nephrology And Urology Devices Market

        • 5.4.9.1. Market Size and Forecast, By Type

      • 5.4.10. Malaysia Nephrology And Urology Devices Market

        • 5.4.10.1. Market Size and Forecast, By Type

      • 5.4.11. Indonesia Nephrology And Urology Devices Market

        • 5.4.11.1. Market Size and Forecast, By Type

      • 5.4.12. Rest of Asia Pacific Nephrology And Urology Devices Market

        • 5.4.12.1. Market Size and Forecast, By Type

    • 5.5. LAMEA

      • 5.5.1. Key Market Trends and Opportunities

      • 5.5.2. Market Size and Forecast, By Type

      • 5.5.3. Market Size and Forecast, By Country

      • 5.5.4. Brazil Nephrology And Urology Devices Market

        • 5.5.4.1. Market Size and Forecast, By Type

      • 5.5.5. South Africa Nephrology And Urology Devices Market

        • 5.5.5.1. Market Size and Forecast, By Type

      • 5.5.6. Saudi Arabia Nephrology And Urology Devices Market

        • 5.5.6.1. Market Size and Forecast, By Type

      • 5.5.7. UAE Nephrology And Urology Devices Market

        • 5.5.7.1. Market Size and Forecast, By Type

      • 5.5.8. Argentina Nephrology And Urology Devices Market

        • 5.5.8.1. Market Size and Forecast, By Type

      • 5.5.9. Rest of LAMEA Nephrology And Urology Devices Market

        • 5.5.9.1. Market Size and Forecast, By Type

  • CHAPTER 6: COMPETITIVE LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top Winning Strategies

    • 6.3. Product Mapping Of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Top Player Positioning,2022

  • CHAPTER 7: COMPANY PROFILES

    • 7.1. Company 1

      • 7.1.1. Company Overview

      • 7.1.2. Key Executives

      • 7.1.3. Company Snapshot

      • 7.1.4. Operating Business Segments

      • 7.1.5. Product Portfolio

      • 7.1.6. Business Performance

      • 7.1.7. Key Strategic Moves and Developments

    • 7.2. Company 2

      • 7.2.1. Company Overview

      • 7.2.2. Key Executives

      • 7.2.3. Company Snapshot

      • 7.2.4. Operating Business Segments

      • 7.2.5. Product Portfolio

      • 7.2.6. Business Performance

      • 7.2.7. Key Strategic Moves and Developments

    • 7.3. Company 3

      • 7.3.1. Company Overview

      • 7.3.2. Key Executives

      • 7.3.3. Company Snapshot

      • 7.3.4. Operating Business Segments

      • 7.3.5. Product Portfolio

      • 7.3.6. Business Performance

      • 7.3.7. Key Strategic Moves and Developments

    • 7.4. Company 4

      • 7.4.1. Company Overview

      • 7.4.2. Key Executives

      • 7.4.3. Company Snapshot

      • 7.4.4. Operating Business Segments

      • 7.4.5. Product Portfolio

      • 7.4.6. Business Performance

      • 7.4.7. Key Strategic Moves and Developments

    • 7.5. Company 5

      • 7.5.1. Company Overview

      • 7.5.2. Key Executives

      • 7.5.3. Company Snapshot

      • 7.5.4. Operating Business Segments

      • 7.5.5. Product Portfolio

      • 7.5.6. Business Performance

      • 7.5.7. Key Strategic Moves and Developments

    • 7.6. Company 6

      • 7.6.1. Company Overview

      • 7.6.2. Key Executives

      • 7.6.3. Company Snapshot

      • 7.6.4. Operating Business Segments

      • 7.6.5. Product Portfolio

      • 7.6.6. Business Performance

      • 7.6.7. Key Strategic Moves and Developments

    • 7.7. Company 7

      • 7.7.1. Company Overview

      • 7.7.2. Key Executives

      • 7.7.3. Company Snapshot

      • 7.7.4. Operating Business Segments

      • 7.7.5. Product Portfolio

      • 7.7.6. Business Performance

      • 7.7.7. Key Strategic Moves and Developments

    • 7.8. Company 8

      • 7.8.1. Company Overview

      • 7.8.2. Key Executives

      • 7.8.3. Company Snapshot

      • 7.8.4. Operating Business Segments

      • 7.8.5. Product Portfolio

      • 7.8.6. Business Performance

      • 7.8.7. Key Strategic Moves and Developments

    • 7.9. Company 9

      • 7.9.1. Company Overview

      • 7.9.2. Key Executives

      • 7.9.3. Company Snapshot

      • 7.9.4. Operating Business Segments

      • 7.9.5. Product Portfolio

      • 7.9.6. Business Performance

      • 7.9.7. Key Strategic Moves and Developments

    • 7.10. Company 10

      • 7.10.1. Company Overview

      • 7.10.2. Key Executives

      • 7.10.3. Company Snapshot

      • 7.10.4. Operating Business Segments

      • 7.10.5. Product Portfolio

      • 7.10.6. Business Performance

      • 7.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET FOR DIALYSIS EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET FOR URINARY STONE TREATMENT DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET FOR URINARY INCONTINENCE PELVIC ORGAN PROLAPSED, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET FOR ENDOSCOPY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. NORTH AMERICA NEPHROLOGY AND UROLOGY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. NORTH AMERICA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 10. U.S. NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 11. CANADA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 12. MEXICO NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 13. EUROPE NEPHROLOGY AND UROLOGY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. EUROPE NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. FRANCE NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 16. GERMANY NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 17. ITALY NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. SPAIN NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. UK NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 20. RUSSIA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. REST OF EUROPE NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. ASIA-PACIFIC NEPHROLOGY AND UROLOGY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. ASIA-PACIFIC NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. CHINA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. JAPAN NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. INDIA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. SOUTH KOREA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. AUSTRALIA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. THAILAND NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 30. MALAYSIA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. INDONESIA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. REST OF ASIA PACIFIC NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 33. LAMEA NEPHROLOGY AND UROLOGY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 34. LAMEA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. BRAZIL NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 36. SOUTH AFRICA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. SAUDI ARABIA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. UAE NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. ARGENTINA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. REST OF LAMEA NEPHROLOGY AND UROLOGY DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. COMPANY 1: KEY EXECUTIVES
  • TABLE 42. COMPANY 1: COMPANY SNAPSHOT
  • TABLE 43. COMPANY 1: OPERATING SEGMENTS
  • TABLE 44. COMPANY 1: PRODUCT PORTFOLIO
  • TABLE 45. COMPANY 1: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 46. COMPANY 2: KEY EXECUTIVES
  • TABLE 47. COMPANY 2: COMPANY SNAPSHOT
  • TABLE 48. COMPANY 2: OPERATING SEGMENTS
  • TABLE 49. COMPANY 2: PRODUCT PORTFOLIO
  • TABLE 50. COMPANY 2: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 51. COMPANY 3: KEY EXECUTIVES
  • TABLE 52. COMPANY 3: COMPANY SNAPSHOT
  • TABLE 53. COMPANY 3: OPERATING SEGMENTS
  • TABLE 54. COMPANY 3: PRODUCT PORTFOLIO
  • TABLE 55. COMPANY 3: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 56. COMPANY 4: KEY EXECUTIVES
  • TABLE 57. COMPANY 4: COMPANY SNAPSHOT
  • TABLE 58. COMPANY 4: OPERATING SEGMENTS
  • TABLE 59. COMPANY 4: PRODUCT PORTFOLIO
  • TABLE 60. COMPANY 4: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 61. COMPANY 5: KEY EXECUTIVES
  • TABLE 62. COMPANY 5: COMPANY SNAPSHOT
  • TABLE 63. COMPANY 5: OPERATING SEGMENTS
  • TABLE 64. COMPANY 5: PRODUCT PORTFOLIO
  • TABLE 65. COMPANY 5: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 66. COMPANY 6: KEY EXECUTIVES
  • TABLE 67. COMPANY 6: COMPANY SNAPSHOT
  • TABLE 68. COMPANY 6: OPERATING SEGMENTS
  • TABLE 69. COMPANY 6: PRODUCT PORTFOLIO
  • TABLE 70. COMPANY 6: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 71. COMPANY 7: KEY EXECUTIVES
  • TABLE 72. COMPANY 7: COMPANY SNAPSHOT
  • TABLE 73. COMPANY 7: OPERATING SEGMENTS
  • TABLE 74. COMPANY 7: PRODUCT PORTFOLIO
  • TABLE 75. COMPANY 7: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. COMPANY 8: KEY EXECUTIVES
  • TABLE 77. COMPANY 8: COMPANY SNAPSHOT
  • TABLE 78. COMPANY 8: OPERATING SEGMENTS
  • TABLE 79. COMPANY 8: PRODUCT PORTFOLIO
  • TABLE 80. COMPANY 8: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. COMPANY 9: KEY EXECUTIVES
  • TABLE 82. COMPANY 9: COMPANY SNAPSHOT
  • TABLE 83. COMPANY 9: OPERATING SEGMENTS
  • TABLE 84. COMPANY 9: PRODUCT PORTFOLIO
  • TABLE 85. COMPANY 9: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. COMPANY 10: KEY EXECUTIVES
  • TABLE 87. COMPANY 10: COMPANY SNAPSHOT
  • TABLE 88. COMPANY 10: OPERATING SEGMENTS
  • TABLE 89. COMPANY 10: PRODUCT PORTFOLIO
  • TABLE 90. COMPANY 10: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEPHROLOGY AND UROLOGY DEVICES MARKET
  • FIGURE 3. SEGMENTATION NEPHROLOGY AND UROLOGY DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEPHROLOGY AND UROLOGY DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEPHROLOGY AND UROLOGY DEVICES MARKET
  • FIGURE 11. NEPHROLOGY AND UROLOGY DEVICES MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. NEPHROLOGY AND UROLOGY DEVICES MARKET FOR DIALYSIS EQUIPMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. NEPHROLOGY AND UROLOGY DEVICES MARKET FOR URINARY STONE TREATMENT DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. NEPHROLOGY AND UROLOGY DEVICES MARKET FOR URINARY INCONTINENCE PELVIC ORGAN PROLAPSED, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. NEPHROLOGY AND UROLOGY DEVICES MARKET FOR ENDOSCOPY DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. NEPHROLOGY AND UROLOGY DEVICES MARKET FOR BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 21. COMPETITIVE DASHBOARD
  • FIGURE 22. COMPETITIVE HEATMAP: NEPHROLOGY AND UROLOGY DEVICES MARKET
  • FIGURE 23. Top player positioning, 2022
  • FIGURE 24. COMPANY 1: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 25. COMPANY 1: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 26. COMPANY 1: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 27. COMPANY 2: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. COMPANY 2: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. COMPANY 2: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. COMPANY 3: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. COMPANY 3: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. COMPANY 3: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. COMPANY 4: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. COMPANY 4: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. COMPANY 4: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. COMPANY 5: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. COMPANY 5: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. COMPANY 5: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. COMPANY 6: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. COMPANY 6: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. COMPANY 6: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. COMPANY 7: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. COMPANY 7: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. COMPANY 7: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. COMPANY 8: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. COMPANY 8: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. COMPANY 8: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. COMPANY 9: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. COMPANY 9: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. COMPANY 9: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. COMPANY 10: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. COMPANY 10: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. COMPANY 10: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Nephrology And Urology Devices Market

Start reading.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers